The global gamma knife market is poised to achieve a significant valuation of USD 337.7 million by 2023, fueled by robust research and development activities. According to market projections, this growth trajectory is expected to create expansive opportunities, with a projected compound annual growth rate (CAGR) of 7.6% from 2023 to 2033. By 2033, the market is anticipated to soar to approximately USD 702.5 million.
A key driver behind this growth is the increasing focus on healthcare initiatives worldwide. Both public and private sector investments aimed at enhancing healthcare infrastructure, particularly in emerging economies, are paving the way for gamma knife providers to extend their market footprint and accessibility.
Elevate Your Business Strategy with Exclusive Insights: Request Checkout Now
Gamma knife technology represents a non-invasive treatment option for various brain disorders, offering precise and targeted radiation therapy. As advancements in medical technology continue to evolve, the demand for gamma knife procedures is expected to rise, further bolstering market expansion.
“The projected growth of the gamma knife market underscores the importance of ongoing research and development efforts,” said FMI. “We anticipate continued innovation in this field to drive adoption rates globally, benefiting patients and healthcare providers alike.”
The promising outlook for the gamma knife market highlights its pivotal role in modern healthcare systems, offering patients minimally invasive treatment options with reduced recovery times compared to traditional surgery.
Key Takeaways from the Market Study:
- Global gamma knife market was valued at USD 313.8 million by 2022-end.
- From 2018 to 2022, the market demand expanded at a CAGR of 7.2%.
- The market in India is expected to expand at a CAGR of 11.4% through 2033.
- By disease, the brain metastases segment to account for a share of 69.2% in 2033.
- From 2023 to 2033, gamma knife market is expected to flourish at a CAGR of 7.6%.
- By 2033, the market value of gamma knife is expected to reach USD 702.5 million.
Gamma knife can complement regenerative medicine and stem cell therapies by providing a precise means of targeting specific areas in the brain for treatment, remarks an FMI analyst.
Gain Strategic Advantage – Get A Full Report
Competitive Landscape:
Prominent players in the gamma knife market are Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, and Hitachi, Ltd., among others.
Recent Developments:
- In 2023, Varian announced the launch of its new Varian gamma knife icon system. The system features a more compact design, improved image guidance, and a faster treatment delivery system.
- In 2022, Akesis announced the launch of its new Akesis Galaxy SRS system. The system is the first and only gamma knife system to use a linear accelerator instead of a cobalt 60 source.
Segmentation Analysis of the Gamma Knife Market
By Disease Indication:
- Brain Metastasis
- Cancer
- Arteriovenous Malformation
- Trigeminal Neuralgia
- Others
By Anatomy:
- Head
- Neck
- Other Body Parts
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube